URN:NBN:SI:DOC-E3BJ2P0Y2016Šega, Sašadocuments/doc/E/URN_NBN_SI_doc-E3BJ2P0Y_001.pdfdocuments/doc/E/URN_NBN_SI_doc-E3BJ2P0Y_001.txt2/367articlestr. 174-1780014-822930047527URN:NBN:SI:doc-E3BJ2P0YslvSlovensko farmacevtsko društvoFarmacevtski vestnikInCdiagnostikaepidemiologijamultipla sklerozatherapyzdravljenje